The science in plain English
Plain-English explainers on GLP-1 nutrition, muscle preservation, side effects and the newest research on Ozempic, Wegovy, Mounjaro and Zepbound. No hype - just what the evidence says.
Do GLP-1 drugs work as well for every ethnicity?
A 2026 meta-analysis found nearly identical percentage weight loss in Asian and non-Asian adults, while one clinic reported Hispanic patients lost less. What the data can and cannot prove about GLP-1 drugs across ethnicities.
Does the Ozempic mouse lifespan study apply to humans?
A 2026 Nature study extended lifespan in aged female mice on semaglutide and mimicked calorie restriction. No human trial shows any GLP-1 drug extends human lifespan. What the mouse evidence proves, and what it does not.
Does Ozempic help or worsen Crohn's and colitis?
Some data link GLP-1 drugs to fewer IBD surgeries, but the best-designed 2026 study found no change in flares. None is approved to treat IBD. The honest, two-sided read.
Does Ozempic cause nerve pain, or help it?
In type 2 diabetes, GLP-1 drugs are linked to less nerve pain. A rarer nerve injury can follow rapid weight loss through vitamin deficiency. What the 2026 evidence shows on both sides.
Is CagriSema better than Ozempic for type 2 diabetes?
In the 2026 REIMAGINE 2 head-to-head, Novo Nordisk's CagriSema edged semaglutide 2.4 mg by 0.16 HbA1c points. Statistically superior, clinically modest. What the pivotal diabetes trials showed.
Can Ozempic or tirzepatide cause ketoacidosis?
Ketoacidosis on GLP-1 drugs is rare. A 2026 review of 25 type 1 diabetes studies found no clear rise; the danger clusters around insulin deficiency, SGLT2 co-use, and unsupervised cosmetic use.
Does Mounjaro protect your heart better than other GLP-1s?
The FDA approved Mounjaro for heart protection in type 2 diabetes on August 28, 2026, but SURPASS-CVOT tested it against another heart-protective GLP-1 and it matched without beating. What noninferiority really means.
Can Ozempic help peripheral artery disease?
In the 2026 STRIDE trial, semaglutide helped people with PAD and diabetes walk about 13% farther, and a large cohort links GLP-1 drugs to fewer amputations. What that proves, and what it does not.
Is Ozempic safe if you have asthma or COPD?
A 2026 review of 123 studies found no rise in respiratory side effects, and large cohorts link GLP-1 drugs to fewer asthma and COPD flare-ups. The evidence, and its limits.
Why does Ozempic give you diarrhea and sulfur burps?
The same drug that constipates one person gives another loose stools and rotten-egg burps. The mechanism, the four-label rates, and what helps.
Does Ozempic cause pancreatitis?
A 2026 meta-analysis of 52 studies found no significant rise in pancreatitis, but the labels still warn about it. What the numbers actually say.
Why does Ozempic make you constipated?
The same slowed gut that curbs appetite hardens your stool. Rates run from about 3% on Ozempic to 24% on Wegovy, plus what actually helps.
Can Ozempic help arthritis and grow new cartilage?
Semaglutide cut knee pain in the 407-person STEP 9 trial, mostly via weight loss. The cartilage-growth claim, though, is still a mouse study.
Does Ozempic cause pancreatic cancer?
The largest review, 60 studies and 4.9 million people, found no increased risk. The label warns about pancreatitis, not cancer, and here is the difference.
Does Ozempic lower blood pressure and raise heart rate?
Blood pressure drifts down about 2 to 5 mm Hg, resting pulse drifts up about 2 to 5 bpm. Both small, and why you should never cut a BP pill on your own.
How many GLP-1 pills are there now?
Four pills are approved, and two are the same drug. A plain map of the diabetes pills, the weight-loss pills, and the one coming next.
Does Ozempic cause joint pain?
43 trials, 100,488 people, no signal. Joint pain is on none of the four US labels, and for knees the evidence leans toward benefit.
Should I tell my dentist I'm on Ozempic?
Ozempic mouth is a patient word, not a label word. Dry mouth appears on exactly one of the four US labels.
Does Ozempic cause thyroid cancer?
15 trials, 84,237 people, no significant increase. The authors still rate their own evidence very low certainty.
Does Ozempic make you more fertile?
The whole "Ozempic babies" evidence base is one 80-woman trial. The birth-control warning is on tirzepatide, not semaglutide.
Can Ozempic damage your eyes?
Europe calls NAION a very rare side effect of semaglutide. The biggest review found no risk, until it removed one study.
How do I deal with Ozempic nausea without quitting?
Nausea hits 44% of Wegovy users versus 16% on placebo. A 2026 clinical guide sets out what to change before you consider stopping.
Does Ozempic stop working when the hunger comes back?
A 60-week Penn trial found semaglutide users still ate 24% to 30% fewer calories at week 60, even after the hunger advantage disappeared.
How much weight can you lose on Foundayo?
Foundayo (orforglipron), the first oral non-peptide GLP-1 pill, was FDA-approved April 1, 2026. Its pivotal trial showed up to 11.1% average weight loss at 72 weeks.
Can semaglutide help people with schizophrenia lose weight?
A CAMH trial is testing weekly semaglutide in 92 adults with schizophrenia who did not respond to metformin, tracking psychiatric symptoms alongside weight.
Retatrutide and TRIUMPH-1: what we know so far
Eli Lilly's triple-agonist hit 24.2% weight loss at 48 weeks in Phase 2. Its Phase 3 trial TRIUMPH-1 has finished, but no results are posted yet.
Can MariTide treat heart failure and obesity?
Amgen's Phase 3 MARITIME-HF trial tests MariTide, a once-monthly GLP-1 agonist and GIP antagonist, in ~5,056 people with obesity and heart failure. Recruiting now - no results yet.
Can tirzepatide help breast cancer survivors lose weight?
Rutgers' FITWISE trial gives 40 breast cancer survivors with obesity weekly tirzepatide, tracking weight loss and 3-year recurrence risk. Recruiting now - no results yet.
Tirzepatide vs semaglutide for HFpEF: what's being studied
A 26,000-patient claims-data study compares tirzepatide and semaglutide in type 2 diabetes with HFpEF. No results yet.
Can tirzepatide help people with type 1 diabetes and obesity?
Eli Lilly's SURPASS-T1D-2 trial tests weekly tirzepatide vs. placebo in adults with type 1 diabetes. No results yet.
Does tirzepatide protect muscle and bone in older adults?
A Wake Forest pilot trial is giving 40 adults over 65 weekly tirzepatide plus protein counseling for 9 months. No results yet.
Can GLP-1 drugs slow biological aging?
A 66-person trial in China is testing whether semaglutide or tirzepatide slow epigenetic aging more than metformin. Recruiting now - no results yet.
Bariatric surgery vs. semaglutide vs. tirzepatide
A Cleveland Clinic trial of 125 adults is running the first head-to-head comparison of bariatric surgery against semaglutide and tirzepatide. Underway now - no results yet.
Can a high-protein diet stop GLP-1 muscle loss?
A new randomized trial of 130 adults in Greece is testing whether high dietary protein preserves more muscle than standard counseling during GLP-1 treatment. Recruiting now - no results yet.
Semaglutide vs tirzepatide: which protects the heart more?
A 2026 real-world study of 21,250 patients found semaglutide cut major cardiovascular events by 22-29% versus tirzepatide - though the study was funded by semaglutide's maker.
How much muscle do you lose on GLP-1 drugs?
A 2025 meta-analysis of 22 RCTs puts the number at 0.86 kg - about 24% of total weight lost. What it means for Ozempic, Wegovy, Mounjaro, and Zepbound users.
Does semaglutide protect your heart? What 22,937 patients show
A 2025 meta-analysis of 10 RCTs found semaglutide cuts heart attack risk by 28%, atrial fibrillation risk by 21%, and angina risk by 23%. What Ozempic and Wegovy users need to know.
Tirzepatide vs semaglutide: which drug loses more weight?
Two independent 2025 meta-analyses covering 142,000+ patients show tirzepatide (Mounjaro, Zepbound) outperforms semaglutide (Ozempic, Wegovy) by roughly 4 kg on average - a gap that grows at higher doses.
Does tirzepatide protect the kidneys better than dulaglutide?
A pre-specified analysis of the SURPASS-CVOT trial in 13,299 patients found tirzepatide cut major kidney events by 23% versus dulaglutide - though Eli Lilly funded the trial and makes both drugs.
Be first to repair your nutritional gaps
Keep the weight loss. Fill the nutritional gap